Polymorphisms in Drug Transporter and Metabolism Genes Associated with Resistance to Imatinib in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis

被引:1
|
作者
Gomez, Ana Marcela Arrieta [1 ]
Diaz-Mendoza, Maria Antonia [2 ]
Lemus, Yesit Bello [1 ]
Leon-Mejia, Grethel [1 ]
Benitez, Martha Lucia Ruiz [1 ]
机构
[1] Univ Simon Bolivar, Fac Ciencias Basicas & Biomed, Ctr Invest Ciencias Vida CICV, Cra 53 Calle 64-51, Barranquilla 080002, Colombia
[2] Univ Costa CUC, Dept Comp Sci & Elect, Barranquilla 080002, Colombia
关键词
LMC; Philadelphia chromosome; polymorphism; translocation; resistance; meta-analysis; CHRONIC MYELOGENOUS LEUKEMIA; TROUGH CONCENTRATION; CLINICAL-RESPONSE; PUBLICATION BIAS; MESYLATE; MDR1; MUTATIONS; CYP3A5-ASTERISK-3; SENSITIVITY; PROGENITORS;
D O I
10.3390/scipharm92010002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this study was to establish the relationship between different polymorphisms in drug transporter and metabolizer genes and resistance to imatinib in chronic myeloid leukemia (CML). For this purpose, an exhaustive search was carried out in the Scopus, Web of Science, and PubMed databases using different combinations of keywords with different inclusion and exclusion criteria. The meta-analysis included nine studies that met the established criteria. The results of the study showed that the polymorphic variants AG and GG of CYP3A5*3 are associated with response to treatment, presenting a significantly lower risk with resistance to imatinib. Likewise, the variants T1236C and G2677T/A of the ABCB1 gene show a significant association with treatment efficacy. In addition, the genetic polymorphism 1236T, homozygous CC of the MDR1 gene, significantly influences the increased risk of cytogenetic relapse and the polymorphic variant 361G>A GA of the SLCO1A2 gene significantly affects the complete molecular response.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] RITUXIMAB FOR CHRONIC LYMPHOCYTIC LEUKEMIA: A SYSTEMATIC REVIEW WITH META-ANALYSIS
    Bauer, K.
    Rancea, M.
    Elter, T.
    Roloff, V.
    Hallek, M.
    Engert, A.
    Skoetz, N.
    HAEMATOLOGICA, 2012, 97 : 305 - 305
  • [32] A systematic review and meta-analysis on antibiotic resistance genes in Ghana
    Donkor, Eric S.
    Odoom, Alex
    Osman, Abdul-Halim
    Darkwah, Samuel
    Kotey, Fleischer C. N.
    BMC MEDICAL GENOMICS, 2025, 18 (01)
  • [33] Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia
    Hoffmann, Verena S.
    Hasford, Joerg
    Deininger, Michael
    Cortes, Jorge
    Baccarani, Michele
    Hehlmann, Ruediger
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (07) : 1311 - 1318
  • [34] Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia
    Verena S. Hoffmann
    Joerg Hasford
    Michael Deininger
    Jorge Cortes
    Michele Baccarani
    Rüdiger Hehlmann
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 1311 - 1318
  • [35] Comparison of cutaneous adverse events between second-generation tyrosine kinase inhibitors and imatinib for chronic myeloid leukemia: a systematic review and meta-analysis
    Cha, Seung-Hyeon
    Kim, Kyungim
    Song, Yun-Kyoung
    ACTA ONCOLOGICA, 2023, 62 (12) : 1767 - 1774
  • [36] The prognostic importance of BCR-ABL transcripts in Chronic Myeloid Leukemia: A systematic review and meta-analysis
    Ghalesardi, Omid Kiani
    Khosravi, Abbas
    Azizi, Ebrahim
    Ahmadi, Seyed Esmaeil
    Hajifathali, Abbas
    Bonakchi, Hossein
    Shahidi, Minoo
    LEUKEMIA RESEARCH, 2021, 101
  • [37] Impact of SLC22A1 and CYP3A5 genotypes on imatinib response in chronic myeloid leukemia: A systematic review and meta-analysis
    Cargnin, Sarah
    Ravegnini, Gloria
    Soverini, Simona
    Angelini, Sabrina
    Terrazzino, Salvatore
    PHARMACOLOGICAL RESEARCH, 2018, 131 : 244 - 254
  • [38] Hematological Adverse Events with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Systematic Review with Meta-Analysis
    Kronick, Olivia
    Chen, Xinyu
    Mehra, Nidhi
    Varmeziar, Armon
    Fisher, Rachel
    Kartchner, David
    Kota, Vamsi
    Mitchell, Cassie S.
    CANCERS, 2023, 15 (17)
  • [39] Tyrosin-Kinase Inhibitors Discontinuation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis
    Campiotti, Leonardo
    Suter, Matteo Basilio
    Gambacorti-Passerini, Carlo
    Onida, Francesco
    Guasti, Luigina
    Grandi, Anna Maria
    Squizzato, Alessandro
    BLOOD, 2015, 126 (23)
  • [40] Constitutional DNA Polymorphisms Associated with the Plasma Imatinib Concentration in Chronic Myeloid Leukemia Patients
    Bruzzoni-Giovanelli, Heriberto
    Zouali, Habib
    Sahbatou, Mourad
    Maneglier, Benjamin
    Cayuela, Jean-Michel
    Rebollo, Angelita
    Marin, Gustavo H.
    Geromin, Daniela
    Tomczak, Carole
    Alberdi, Antonio
    Deleuze, Jean-Francois
    Rousselot, Philippe
    PHARMACEUTICS, 2024, 16 (06)